NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

I believe that it could have, but you need to understand that DNDN's drug didn't have nearly the potential of DCVAX-L. The question may have been that if DNDN earned enough to stay in business, could they have developed a product similar to DCVAX-L.

Gary